MYRIAD GENETICS INC (MYGN) Stock Cash Flow
USA - NASDAQ:MYGN - US62855J1043 - Common Stock
8.15 USD
+0.1 (+1.24%)
8.3 USD
+0.15 (+1.84%)
| TTM (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -395.20M | -127.30M | -263.30M | -112.00M | -27.20M | |||
| Depreciation Amortization | 58.70M | 61.20M | 61.90M | 52.70M | 62.80M | |||
| Income Taxes - Deferred | N/A | -2.80M | -4.00M | -30.80M | -32.10M | |||
| Change In Working Capital | -68.50M | -54.40M | 10.70M | -101.50M | 120.40M | |||
| Interest Paid | 2.90M | 1.90M | 1.40M | N/A | N/A | |||
| Taxes Paid | 1.70M | 2.70M | 1.90M | 1.80M | -85.40M | |||
| Other non cash items | 385.90M | 114.60M | 83.80M | 85.30M | -105.70M | |||
| OPERATING CASH FLOW | -20.60M | -8.70M | -110.90M | -106.30M | 18.20M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -26.90M | -29.70M | -73.30M | -45.30M | -18.00M | |||
| Other Investing Activity | 13.80M | 17.80M | 105.20M | -32.20M | 292.40M | |||
| INVESTING CASH FLOW | -13.10M | -11.90M | 31.90M | -77.50M | 274.40M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | 19.60M | 100.00K | 39.80M | 0.00 | -226.40M | |||
| Stock Issued/Repurchased | -4.40M | -7.50M | 114.80M | -4.30M | 80.30M | |||
| Other Financing Activity | N/A | 0.00 | -1.70M | -3.70M | -4.50M | |||
| FINANCING CASH FLOW | 15.20M | -7.40M | 152.90M | -8.00M | -150.60M | |||
| Exchange Rate Effect | 1.20M | -1.00M | 600.00K | -600.00K | -600.00K | |||
| CHANGE IN CASH | -17.30M | -29.00M | 74.50M | -192.40M | 141.40M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -20.60M | -8.70M | -110.90M | -106.30M | 18.20M | |||
| Capital Expenditure | -26.90M | -29.70M | -73.30M | -45.30M | -18.00M | |||
| FREE CASH FLOW | -47.50M | -38.40M | -184.20M | -151.60M | 200.00K | |||
All data in USD